Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,175 | -2,594 | -1,775 | -1,241 | -3,457 |
| Depreciation Amortization | 139 | 106 | 72 | 36 | 138 |
| Income taxes - deferred | -231 | 200 | 141 | 93 | 357 |
| Accounts receivable | -122 | 46 | -294 | -216 | 434 |
| Accounts payable and accrued liabilities | 871 | 589 | 360 | 1,026 | 416 |
| Other Working Capital | -921 | -1,246 | -1,184 | -960 | 2,650 |
| Other Operating Activity | -494 | -515 | 30 | -753 | -626 |
| Operating Cash Flow | $-3,933 | $-3,414 | $-2,650 | $-2,015 | $-88 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -192 | -163 | -116 | -106 | -80 |
| Investing Cash Flow | $-192 | $-163 | $-116 | $-106 | $-80 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 277 | N/A | N/A | N/A | 274 |
| Common Stock Issued | 471 | 310 | 44 | 23 | 3,161 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1 |
| Other Financing Activity | -271 | -220 | -164 | -81 | -404 |
| Financing Cash Flow | $477 | $90 | $-120 | $-58 | $3,030 |
| Exchange Rate Effect | 673 | 674 | 547 | 410 | -616 |
| Beginning Cash Position | 5,374 | 5,374 | 5,374 | 5,374 | 3,128 |
| End Cash Position | 2,399 | 2,561 | 3,035 | 3,605 | 5,374 |
| Net Cash Flow | $-2,975 | $-2,813 | $-2,339 | $-1,769 | $2,246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,933 | -3,414 | -2,650 | -2,015 | -88 |
| Capital Expenditure | -192 | -163 | -116 | -106 | -80 |
| Free Cash Flow | -4,125 | -3,577 | -2,766 | -2,121 | -168 |